It is well-established that the host organism sequentially produces antibodies against various EBV antigens (CA, EA, NA) following the infection, with IgM and IgG antibodies against EBV-CA being generated at an early stage, followed by antibodies against EBV-EA. This evidence concerns the gene CD40LG and infection.